[go: up one dir, main page]

HN2002000377A - Peptidos para el tratamiento del cancer asociado al virus papiloma humano (v p h ) y de otros tumores epiteliales - Google Patents

Peptidos para el tratamiento del cancer asociado al virus papiloma humano (v p h ) y de otros tumores epiteliales

Info

Publication number
HN2002000377A
HN2002000377A HN2002000377A HN2002000377A HN2002000377A HN 2002000377 A HN2002000377 A HN 2002000377A HN 2002000377 A HN2002000377 A HN 2002000377A HN 2002000377 A HN2002000377 A HN 2002000377A HN 2002000377 A HN2002000377 A HN 2002000377A
Authority
HN
Honduras
Prior art keywords
epitelial
tumors
treatment
peptides
cancer associated
Prior art date
Application number
HN2002000377A
Other languages
English (en)
Inventor
Silvio Ernesto Perea Rodriguez
Osvaldo Reyes Acosta
Nelson Francisco Santiago Vispo
Yaquelin Puchades Izaguirre
Ricardo Silva Rodriguez
Alejandro Moro Soria
Alicia Santos Savio
Luis Javier Gonzales Lopez
Belkis Gonzalez Barrios
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Publication of HN2002000377A publication Critical patent/HN2002000377A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PEPTIDOS UTILES PARA EL TRATAMIENTO DE TUMORES DE ORIGEN EPITELIAL Y ESPECIALMENTE LOS ASOCIADOS A TIPOS ONCOGENICOS DE VIRUS PAPILOMA ( VPH )
HN2002000377A 2001-12-20 2002-12-19 Peptidos para el tratamiento del cancer asociado al virus papiloma humano (v p h ) y de otros tumores epiteliales HN2002000377A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20010309A CU23225A1 (es) 2001-12-20 2001-12-20 PéPTIDOS PARA EL TRATAMIENTO DEL CáNCER ASOCIADO AL VIRUS PAPILOMA HUMANO (VPH) Y DE OTROS TUMORES EPITELIALES

Publications (1)

Publication Number Publication Date
HN2002000377A true HN2002000377A (es) 2003-04-10

Family

ID=40091679

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2002000377A HN2002000377A (es) 2001-12-20 2002-12-19 Peptidos para el tratamiento del cancer asociado al virus papiloma humano (v p h ) y de otros tumores epiteliales

Country Status (33)

Country Link
US (2) US7374767B2 (es)
EP (2) EP1491553B1 (es)
JP (1) JP4056476B2 (es)
KR (1) KR100642437B1 (es)
CN (1) CN100368431C (es)
AR (1) AR037825A1 (es)
AT (1) ATE520704T1 (es)
AU (1) AU2002361922B2 (es)
BR (1) BRPI0215213C1 (es)
CA (1) CA2471110C (es)
CR (1) CR7361A (es)
CU (1) CU23225A1 (es)
DK (1) DK1491553T3 (es)
DO (1) DOP2002000548A (es)
ES (1) ES2371239T3 (es)
HN (1) HN2002000377A (es)
HR (1) HRP20040663B1 (es)
IL (2) IL162633A0 (es)
IS (1) IS2906B (es)
MA (1) MA27868A1 (es)
MX (1) MXPA04005832A (es)
MY (1) MY133530A (es)
NO (1) NO333259B1 (es)
NZ (1) NZ534170A (es)
PE (1) PE20030861A1 (es)
PT (1) PT1491553E (es)
RU (1) RU2290410C2 (es)
SI (1) SI1491553T1 (es)
TN (1) TNSN04114A1 (es)
UA (1) UA81403C2 (es)
UY (1) UY27602A1 (es)
WO (1) WO2003054002A1 (es)
ZA (1) ZA200405514B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23225A1 (es) * 2001-12-20 2007-08-30 Ct Ingenieria Genetica Biotech PéPTIDOS PARA EL TRATAMIENTO DEL CáNCER ASOCIADO AL VIRUS PAPILOMA HUMANO (VPH) Y DE OTROS TUMORES EPITELIALES
CU23431B6 (es) * 2005-05-12 2009-10-16 Ct Ingenieria Genetica Biotech Método para la inhibición de la proliferación de células tumorales y el tratamiento del cáncer
GB2433740A (en) 2005-12-23 2007-07-04 Rapid Biosensor Systems Ltd Detection of tuberculosis infection
CU23511B6 (es) * 2006-02-28 2010-04-13 Biorec B V Combinación farmacéutica para el tratamiento y/o quimiosensibilización de tumores refractarios a drogas anticancerígenas
GB2441131A (en) * 2006-08-24 2008-02-27 Univ Dundee Modulation of binding of CK2a to NDPK
CN100522992C (zh) * 2007-02-12 2009-08-05 中国科学院昆明动物研究所 一种环状小肽ba
US20110052725A1 (en) * 2007-03-27 2011-03-03 Takashi Shibata Therapeutic agent for infectious skin and mucosal disease
US20110305706A1 (en) 2009-02-23 2011-12-15 Scott Thomas Brady Compositions and Methods for Treating a Disease Mediated by Soluble Oligomeric Amyloid Beta
EP2406379A4 (en) * 2009-03-13 2012-09-26 Egen Inc COMPOSITIONS AND METHODS FOR RELEASING BIOLOGICALLY ACTIVE RNA
CN108712911A (zh) 2015-12-30 2018-10-26 科达制药股份有限公司 抗体及其缀合物
CU20200103A7 (es) * 2020-12-18 2022-07-08 Ct Ingenieria Genetica Biotecnologia Péptido sintético para la inducción de inmunidad antitumoral y antiviral
CU24766B1 (es) 2021-07-09 2025-08-13 Ct Ingenieria Genetica Biotecnologia Péptidos lineales que inhiben la fosforilación mediada por ck2
CN118370805B (zh) * 2024-04-29 2025-02-14 广州中科佰氏健康产业有限公司 一种抑菌妇科凝胶及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE902820A1 (en) 1989-08-07 1991-02-27 Merck & Co Inc Peptide inhibitors of human papilloma virus protein binding¹to retinoblastoma gene proteins
JPH05310784A (ja) * 1991-09-04 1993-11-22 Merck & Co Inc ヒト乳頭腫ウイルスタンパク質と網膜芽細胞腫遺伝子タンパク質との結合のペプチド阻害剤
GB9313556D0 (en) * 1993-07-01 1993-08-18 British Tech Group Synthetic peptides of human papillomavirus
US5625031A (en) * 1994-02-08 1997-04-29 Bristol-Myers Squibb Company Peptide inhibitors of the p33cdk2 and p34cdc2 cell cycle regulatory kinases and human papillomavirus E7 oncoprotein
ATE235509T1 (de) 1998-06-30 2003-04-15 Deutsches Krebsforsch Peptide zur inhibition von hpv e7 proteinen
US6641994B2 (en) 1999-08-25 2003-11-04 Pharmacia & Upjohn Company Methods of identifying anti-viral agents
AU2001238347A1 (en) * 2000-02-28 2001-09-12 Hyseq, Inc. Novel nucleic acids and polypeptides
CU23225A1 (es) * 2001-12-20 2007-08-30 Ct Ingenieria Genetica Biotech PéPTIDOS PARA EL TRATAMIENTO DEL CáNCER ASOCIADO AL VIRUS PAPILOMA HUMANO (VPH) Y DE OTROS TUMORES EPITELIALES

Also Published As

Publication number Publication date
CA2471110A1 (en) 2003-07-03
NO20043112L (no) 2004-07-20
NZ534170A (en) 2006-08-31
CU23225A1 (es) 2007-08-30
ES2371239T3 (es) 2011-12-28
IS2906B (is) 2014-11-15
BRPI0215213C1 (pt) 2021-05-25
EP1491553A1 (en) 2004-12-29
US7374767B2 (en) 2008-05-20
PT1491553E (pt) 2011-11-25
MY133530A (en) 2007-11-30
SI1491553T1 (sl) 2011-12-30
KR20050002811A (ko) 2005-01-10
CN100368431C (zh) 2008-02-13
IL162633A (en) 2011-02-28
WO2003054002A1 (es) 2003-07-03
JP4056476B2 (ja) 2008-03-05
TNSN04114A1 (en) 2006-06-01
AR037825A1 (es) 2004-12-09
HRP20040663A2 (en) 2005-08-31
BRPI0215213B1 (pt) 2018-09-11
CR7361A (es) 2005-02-18
EP2383282A1 (en) 2011-11-02
HRP20040663B1 (hr) 2013-05-31
US7947287B2 (en) 2011-05-24
IL162633A0 (es) 2005-11-20
MXPA04005832A (es) 2004-09-13
UY27602A1 (es) 2003-04-30
HK1068901A1 (en) 2005-05-06
AU2002361922A1 (en) 2003-07-09
ZA200405514B (en) 2005-03-30
JP2005525090A (ja) 2005-08-25
UA81403C2 (en) 2008-01-10
DOP2002000548A (es) 2003-06-30
ATE520704T1 (de) 2011-09-15
RU2290410C2 (ru) 2006-12-27
RU2004122084A (ru) 2005-03-27
DK1491553T3 (da) 2011-12-05
CN1620464A (zh) 2005-05-25
MA27868A1 (fr) 2006-05-02
US20090005294A1 (en) 2009-01-01
NO333259B1 (no) 2013-04-22
PE20030861A1 (es) 2003-12-02
US20060233742A1 (en) 2006-10-19
IS7320A (is) 2004-06-16
AU2002361922B2 (en) 2007-04-05
EP1491553B1 (en) 2011-08-17
KR100642437B1 (ko) 2006-11-06
CA2471110C (en) 2017-01-31
BR0215213A (pt) 2004-12-07

Similar Documents

Publication Publication Date Title
HN2002000377A (es) Peptidos para el tratamiento del cancer asociado al virus papiloma humano (v p h ) y de otros tumores epiteliales
CO5700784A2 (es) Polipeptidos de virus de papiloma humano y composiciones in- munogenas
EP1712235A3 (en) Combinational therapy involving a small molecule inhibitor of the MDM2: P53 interaction
PA8571001A1 (es) 2-(2,6-diclorofenil)-diarilimidazoles
CY1110254T1 (el) Φαινυλακεταμιδια και χρησις των ως διαμορφωται γλυκοκινασης
NZ613252A (en) Peptide epoxyketones for proteasome inhibition
SG140589A1 (en) Therapy device and related accessories, compositions, and treatment methods
DK1519724T3 (da) Fredericamycin-derivater som lægemidler til behandling af tumorer
ATE380552T1 (de) Pharmazeutische zusammensetzung enthältend estetrolderivate und anwendung in der krebsbehandlung
EA200101046A1 (ru) Производные индигоидных бис-индолов
CY1111721T1 (el) Ακυλαμινοπυραζολια ως αναστολεις fgfr
AR032912A1 (es) Formulacion farmaceutica
BR0313747A (pt) Inibidores de transcriptase reversa de não-nucleosìdeo
BR0308606A (pt) Derivados de hemiasterlina e usos destes
ATE478662T1 (de) Arzneilösungen enthaltend modafinilverbindungen
SG155898A1 (en) Treatment of diseases using nalmefene and its analogs
ATE431742T1 (de) Modifizierte zytokine für krebs therapie
ATE439126T1 (de) Antitumorale terpen-verbindungen
PT1399142E (pt) Utilizacao de acetil-l-carnitina em associacao com biotina para o tratamento de doentes com diabetes mellitus insulino-resistente do tipo 2
ATE383154T1 (de) Kombinierte tumortherapie auf der basis von distamycin-acryloyl derivaten und radiotherapie
AR014768A1 (es) Medicamento para evitar o tratar los tumores especificos de los virus del papiloma humano que contiene por lo menos una proteina de fusion de por lomenos una proteina l1 de uno o mas virus del papiloma y de por lo menos una proteina e de uno o mas virus de papiloma, un procedimiento para su preparac
MX9706086A (es) Preparaciones farmaceuticas para inhibicion de tnf.
UA87292C2 (ru) Применение сирамезина для лечения злокачественных опухолей
DE60203740D1 (de) Luminacine analoge und deren verwendung
ES2181586B1 (es) Producto farmaceutico para el tratamiento de tumores cancerigenos.